---
$id: https://graph.org.ai/products/commodity/51142558
$type: Product
source: UNSPSC
code: "51142558"
title: "Mofegiline hydrochloride"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Mofegiline hydrochloride

**UNSPSC Code**: 51142558
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a monoamine oxidase inhibitor C11H13F2N.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 08331R10RY, chemically known as benzenebutanamine, 4-fluoro-.beta.-(fluoromethylene)-, hydrochloride, (e)-, but more generally known as mofegiline hydrochloride, which bears US NIH Compound Identifier 3047771. Most nations, for tariff and trade purposes, schedule mofegiline hydrochloride under HS 29214980 and SITC 51454. As of Q4 2014, MOFEGILINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Mofegiline hydrochloride bears US NLM identifiers UMLS ID C2825395 and NCI Concept Code C80965. SMILES: C1CC(CCC1CC/C(=C\F)/CN)F.CL.

